Fig. 2. Relationship between SHBG assessed at 24 months post-baseline and trait anxiety (assessed at baseline) for women receiving 10 mg of tamoxifen (N= 59) and women receiving placebo (N= 58) twice daily for a 24-month period. The linear functions are estimated values based on hierarchical regression analyses of the data provided by the participants in this randomized trial, all of whom had breast cancer in remission.

Return to article